30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Healthcare Sector Insider Trading Activity

Track insider buying and selling in Healthcare stocks. See which executives are buying, net insider activity, and % of float traded across 3,186 companies.
The information provided in this screen is for informational purposes only and does not constitute financial advice. We do not endorse any specific investment based on these criteria.
Companies
Data
Subscribe to access full data
Company Business Sector Market cap ($) # net buying insiders Net value bought ($) % of float bought % of shares held by insiders
Pharmaceuticals & Medical Research Mega (1.0tn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Mega (589.5bn) -1–5 -$1M–$10M -0–15% 0–15%
US Abbvie Inc (ABBV)
Pharmaceuticals & Medical Research Mega (429.6bn) 0 No activity — 0–15%
Healthcare Services Mega (377.4bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mega (326.2bn) 0 No activity — —
Pharmaceuticals & Medical Research Mega (309.8bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mega (290.1bn) -1–5 -$1M–$10M -0–15% 0–15%
CH Novartis AG (NOVN)
Pharmaceuticals & Medical Research Mega (287.4bn) -1–5 -$1M–$10M -0–15% 0–15%
US Amgen Inc (AMGN)
Pharmaceuticals & Medical Research Large (179.0bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (167.0bn) 0 No activity — 0–15%
DK Novo Nordisk A/S (NOVO-B)
Pharmaceuticals & Medical Research Large (164.0bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (155.9bn) 0 No activity — 0–15%
Healthcare Services Large (154.2bn) 1–5 $1M–$10M 0–15% 0–15%
Healthcare Services Large (150.4bn) 0 No activity — 0–15%
US Pfizer Inc (PFE)
Pharmaceuticals & Medical Research Large (146.5bn) -1–5 -< $100K -0–15% 0–15%
Healthcare Services Large (130.0bn) -1–5 -$100M+ -0–15% 0–15%
US Stryker Corp (SYK)
Healthcare Services Large (120.0bn) -1–5 -$10M–$100M -0–15% 0–15%
US Danaher Corp (DHR)
Healthcare Services Large (116.5bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (115.6bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (112.9bn) 0 No activity — 0–15%
FR Sanofi SA (SAN)
Pharmaceuticals & Medical Research Large (107.6bn) 0 No activity — 0–15%
Healthcare Services Large (107.4bn) 0 No activity — 0–15%
GB GSK plc (GSK)
Pharmaceuticals & Medical Research Large (101.7bn) 11–20 $100K–$1M 0–15% 0–15%
Healthcare Services Large (97.5bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (96.7bn) 0 No activity — 15–50%
Healthcare Services Large (90.8bn) -1–5 -$100K–$1M -0–15% 0–15%
AU CSL Ltd (CSL)
Pharmaceuticals & Medical Research Large (90.6bn) 0 No activity — 0–15%
US Celgene Corp (CELG)
Pharmaceuticals & Medical Research Large (77.0bn) 0 No activity — —
Pharmaceuticals & Medical Research Large (73.5bn) 0 No activity — 0–15%
Healthcare Services Large (72.1bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (67.3bn) 1–5 $100K–$1M 0–15% 0–15%
US Medline Inc (MDLN)
Healthcare Services Large (65.3bn) -1–5 -$100M+ -15–50% 0–15%
US Allergan plc (AGN)
Pharmaceuticals & Medical Research Large (63.7bn) 0 No activity — 0–15%
BE Ucb SA (UCB)
Pharmaceuticals & Medical Research Large (59.7bn) 0 No activity — 15–50%
NL argenx SE (ARGX)
Pharmaceuticals & Medical Research Large (57.8bn) -1–5 -$1M–$10M -0–15% —
US Cencora Inc (COR)
Healthcare Services Large (54.7bn) 1–5 $1M–$10M 0–15% 0–15%
Healthcare Services Large (50.1bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (47.7bn) 0 No activity — 0–15%
US Humana Inc (HUM)
Healthcare Services Large (45.1bn) 0 No activity — 0–15%
Healthcare Services Large (44.7bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Large (43.3bn) 1–5 $100K–$1M 0–15% 0–15%
US Seagen Inc (SGEN)
Pharmaceuticals & Medical Research Large (43.2bn) 0 No activity — 0–15%
Healthcare Services Large (43.1bn) 0 No activity — 0–15%
DE Bayer AG (BAYN)
Pharmaceuticals & Medical Research Large (41.8bn) 1–5 $1M–$10M 0–15% —
Pharmaceuticals & Medical Research Large (40.1bn) 0 No activity — 0–15%
GB Haleon PLC (HLN)
Pharmaceuticals & Medical Research Large (40.1bn) 1–5 $100K–$1M 0–15% 0–15%
Healthcare Services Large (39.7bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (39.1bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (38.8bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (37.7bn) -1–5 -$100K–$1M -0–15% 0–15%
US Waters Corp (WAT)
Healthcare Services Large (36.2bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (36.1bn) 0 No activity — 0–15%
US Zoetis Inc (ZTS)
Pharmaceuticals & Medical Research Large (34.1bn) 1–5 $100K–$1M 0–15% 0–15%
US Centene Corp (CNC)
Healthcare Services Large (32.1bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (32.0bn) 0 No activity — 50%+
CH Alcon AG (ALC)
Healthcare Services Large (30.8bn) 1–5 $100K–$1M 0–15% 0–15%
Pharmaceuticals & Medical Research Large (30.5bn) 0 No activity — 0–15%
Healthcare Services Large (29.9bn) 0 No activity — 0–15%
US Biogen Inc (BIIB)
Pharmaceuticals & Medical Research Large (29.8bn) 0 No activity — 0–15%
Healthcare Services Large (29.1bn) 1–5 $10M–$100M 50%+ 15–50%
US DexCom Inc (DXCM)
Healthcare Services Large (28.2bn) 0 No activity — 0–15%
US Cerner Corp (CERN)
Healthcare Services Large (27.9bn) 0 No activity — 0–15%
Healthcare Services Large (27.8bn) 6–10 $1M–$10M 0–15% 0–15%
US Resmed Inc (RMD)
Healthcare Services Large (27.0bn) 0 No activity — 0–15%
Healthcare Services Large (26.8bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Large (26.6bn) 0 No activity — 0–15%
US Illumina Inc (ILMN)
Healthcare Services Large (25.0bn) -1–5 -$100M+ -0–15% 0–15%
US Moderna Inc (MRNA)
Pharmaceuticals & Medical Research Large (24.5bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (24.0bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (23.9bn) -1–5 -$10M–$100M -0–15% 15–50%
US Steris Ltd (STE)
Healthcare Services Large (23.9bn) 0 No activity — 0–15%
DE Biontech SE (BNTX)
Pharmaceuticals & Medical Research Large (23.3bn) -1–5 -$1M–$10M -0–15% 50%+
Healthcare Services Large (23.2bn) 1–5 $1M–$10M 0–15% 15–50%
Pharmaceuticals & Medical Research Large (23.2bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (21.7bn) 0 No activity — 0–15%
US Incyte Corp (INCY)
Pharmaceuticals & Medical Research Large (21.5bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (21.4bn) 0 No activity — 0–15%
US Insmed Inc (INSM)
Pharmaceuticals & Medical Research Large (21.4bn) -1–5 -$1M–$10M -0–15% 0–15%
IE STERIS plc (STE)
Healthcare Services Large (20.8bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (20.3bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (20.0bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (18.9bn) -1–5 -$1M–$10M -0–15% 50%+
Healthcare Services Large (18.9bn) 1–5 $100K–$1M 0–15% 15–50%
US Viatris Inc (VTRS)
Pharmaceuticals & Medical Research Large (18.3bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (18.2bn) -11–20 -$10M–$100M -0–15% 0–15%
Healthcare Services Large (17.9bn) 0 No activity — 50%+
Healthcare Services Large (17.4bn) -1–5 -$100K–$1M -0–15% 0–15%
US ABIOMED Inc (ABMD)
Healthcare Services Large (17.2bn) 0 No activity — 0–15%
US Hologic Inc (HOLX)
Healthcare Services Large (16.9bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (16.6bn) -6–10 -$1M–$10M -0–15% 0–15%
DK Genmab A/S (GMAB)
Pharmaceuticals & Medical Research Large (16.5bn) 0 No activity — —
Pharmaceuticals & Medical Research Large (16.5bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (16.0bn) 1–5 -$1M–$10M -0–15% 0–15%
IN Cipla Ltd (CIPLA)
Pharmaceuticals & Medical Research Large (15.9bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Large (15.7bn) 0 No activity — 50%+
Healthcare Services Large (15.2bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (15.1bn) -1–5 -$1M–$10M -0–15% 0–15%
FR Ipsen SA (IPN)
Pharmaceuticals & Medical Research Large (15.0bn) 0 No activity — 50%+
Healthcare Services Large (14.1bn) 1–5 $100K–$1M 0–15% 15–50%
Pharmaceuticals & Medical Research Large (14.0bn) 0 No activity — 0–15%